Skin cancer risk for patients with vitiligo does not increase after UVB phototherapy

For patients with vitiligo, extended treatment with narrowband ultraviolet B (UVB) phototherapy does not lead to an increase in their risk of developing skin cancer, according to a new study. The study, published online ahead of print in JAMA Dermatology (Mar. 11, 2020), took a deeper look at UVB phototherapy, which is often used for vitiligo patients.

Mercury exposure may increase risk of skin cancer

Exposure to mercury could lead to an increased risk of developing non-melanoma skin cancer, according to a new study. The study, published online ahead of print in the British Journal of Dermatology (Feb. 5, 2020), used information from the National Health and Nutrition Examination Survey to cross track mercury exposure from fish and skin cancer rates.